Among tumor lines with Hippo pathway mutations analyzed by us, one mesothelioma, H2052, with both LATS2 and NF2 mutations, was found to be resistant to XAV939 despite its striking sensitivity to dnTEAD4 inhibition of TEAD-mediated transcription and proliferation. The gene discussed is LATS2; the disease is neoplasm.